IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

June 30, 2018

Conditions
Inflammatory Bowel DiseaseCrohn's Disease
Interventions
BIOLOGICAL

Infliximab

Patients will be prescribed Infliximab as a standard of care regardless of study participation.

Trial Locations (2)

Unknown

Stollery Children's Hospital, Edmonton

M5G 1X8

SickKids, Toronto

All Listed Sponsors
collaborator

The Hospital for Sick Children

OTHER

collaborator

The Children's Hospital of Winnipeg

OTHER

collaborator

Alberta Children's Hospital

OTHER

collaborator

Provincial Health Services Authority

OTHER

collaborator

Children's Hospital of Eastern Ontario

OTHER

lead

University of Alberta

OTHER

NCT02847884 - IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study | Biotech Hunter | Biotech Hunter